Review of actual benefit in accordance with article R. 163-21 of the Social Security Code.
-
Clinical Benefit
Insufficient
In the absence of new clinical data, the transparency Committee confirms that the actual benefit of DIDRONEL 200 mg, in comparison with the treatments that are already available, is not sufficient to allow it to be refundable by National Health Insurance.
DIDRONEL 400 mg In view of all these factors, the actual benefit of this proprietary drug must be regarded as insufficient to justify public funding in view of the other treatments available.
Listen
